Comparative Clinical and Radiographic Evaluation of the Efficacy of Beta Tricalcium Phosphate (AliveossÃ?Â®) with Titanium Platelet Rich Fibrin (T-PRF ) and Beta Tricalcium Phosphate (AliveossÃ?Â® ) with Injectable Platelet Rich Fibrin (i-PRF) in the Treatment of Intrabony Defects in Chronic Periodontitis Patients Ã¢â?¬â?? A Randomized Clinical Trial

Dr Sayali Gotpagar0 个研究点目标入组 0 人开始时间: 待定最近更新: 2022年10月17日

试验速览

暂无简介。

•1)Patients diagnosed with Chronic Periodontitis.
•2)Patients who are non smokers or do not consume tobacco in any other form.
•3)Patients are in good systemic health with no contraindication to periodontal surgery.
•4)Patients having pocket depths >5mm, intraosseous defects > 3mm and with radiographic
•evidence of vertical / angular bone loss in the affected sites.
•5)Involved teeth to be vital and asymptomatic.

•1) One-walled osseous defects.
•2) Patients suffering from any systemic diseases or with a compromised immune system.
•3) Patients who had received any type of periodontal therapy for the past 6 months.
•4) Patients taking immunosuppressant drugs like corticosteroids.
•5) Patients with a known history of allergy to Doxycycline or Chlorhexidine or any other
•medicine used in the study.
•6) Patients showing unacceptable oral hygiene compliance during / after Phase I
•periodontal therapy.
•7) Patients taking any drug known to cause gingival enlargement.
•8) Pregnant and/or lactating mothers.

发起方

Dr Sayali Gotpagar